Skip to content

Effect of PTI-guided intraoperative remifentanil titration on tourniquet-induced hypertension in patients undergoing knee arthroscopy: a randomized controlled trial

Effect of PTI-guided intraoperative remifentanil titration on tourniquet-induced hypertension in patients undergoing knee arthroscopy: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120270
Enrollment
Unknown
Registered
2026-03-11
Start date
2026-03-11
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

L-group:In Group L, the remifentanil infusion rate was regulated according to the PTi monitoring results from the HXD-I Multifunctional Monitor, with the PTI maintained within the target range of 45–5
D-group:In Group D, the remifentanil infusion rate was adjusted based on the patients' vital signs, the intensity of surgical stimulation, and the clinicians’ clinical experience.

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 65 years. 2.American Society of Anesthesiologists physical status classification ?-? . 3.Scheduled for elective knee arthroscopy under general anesthesia.

Exclusion criteria

Exclusion criteria: 1.Ischemic heart disease, uncontrolled hypertension, hepatic or renal insufficiency. 2.Chronic use of opioid analgesics, sedatives or antidepressants. 3.A history of schizophrenia, epilepsy, Parkinson's disease or myasthenia gravis. 4.Contraindications to tourniquet use (e.g., peripheral vascular disease, peripheral neuropathy). 5.Tourniquet inflation time of less than 30 minutes or more than 120 minutes.

Design outcomes

Primary

MeasureTime frame
Intraoperative incidence of tourniquet-induced hypertension ;

Secondary

MeasureTime frame
Intraoperative hypotension incidence rate;Administration status of intraoperative vasoactive drugs;NRS pain scores preoperatively and at 1, 6, 12, and 48 hours postoperatively;Quality of Recovery Scores preoperatively and at 24 hours postoperatively;Consumption of analgesic drugs within 48 hours postoperatively;Postoperative nausea and vomiting, dizziness, and psychiatric-related adverse effects;

Countries

China

Contacts

Public ContactChen Lijian

The First Affiliated Hospital of Anhui Medical University

chenlijian77@shmu.edu.cn+86 139 6669 9467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026